Ownership and insider activity for Surgery Partners, Inc. (SGRY): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services.
Price
| Price | $23.21 (closing price, October 30, 2026) |
| Market Cap | $3.0B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-18 | DeLuca Teresa | P-Purchase | 11,250 | $161K |
| 2026-08-18 | DeLuca Teresa | P-Purchase | 10,000 | $144K |
| 2026-06-18 | HENDRIX BLAIR E | A-Award | 34,364 | $500K |
| 2026-06-05 | HENDRIX BLAIR E | A-Award | 11,670 | $160K |
| 2026-06-05 | Deane John A | A-Award | 11,670 | $160K |
| 2026-06-05 | Forese Laura L | A-Award | 11,670 | $160K |
| 2026-06-05 | ADLERZ CLIFFORD G | A-Award | 11,670 | $160K |
| 2026-06-05 | Dean Lloyd H | A-Award | 11,670 | $160K |
| 2026-06-05 | DeLuca Teresa | A-Award | 11,670 | $160K |
| 2026-06-05 | TURNER BRENT | A-Award | 11,670 | $160K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $69.7M | $174.9M | $184.3M | $92.7M | $317.9M | $389.9M | $282.9M | $195.9M | $269.5M | $239.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $227.6M | $295.6M | $316.1M | $326.9M | $382.2M | $430.2M | $456.3M | $496.4M | $579.1M | $602.2M |
| Inventory | $28.8M | $45.0M | $43.4M | $46.3M | $56.4M | $61.1M | $71.4M | $75.2M | $88.4M | $96.6M |
| Total Current Assets | $362.0M | $563.2M | $588.3M | $525.5M | $801.5M | $946.1M | $921.0M | $895.0M | $1.12B | $1.15B |
| Property, Plant & Equipment | $204.3M | $398.5M | $426.3M | $821.0M | $854.7M | $953.8M | $1.16B | $1.22B | $1.38B | $1.44B |
| Goodwill | $1.56B | $3.35B | $3.38B | $3.40B | $3.47B | $3.91B | $4.14B | $4.33B | $5.07B | $5.19B |
| Intangible Assets | $48.0M | $58.9M | $54.3M | $47.3M | $46.9M | $43.7M | $42.3M | $54.8M | $45.7M | $41.0M |
| Total Assets | $2.30B | $4.62B | $4.68B | $5.02B | $5.41B | $6.12B | $6.68B | $6.88B | $7.89B | $8.24B |
| Accounts Payable | $49.8M | $84.7M | $83.3M | $96.7M | $100.2M | $124.9M | $151.6M | $171.8M | $208.7M | $208.7M |
| Short-term Debt | $27.8M | $58.7M | $55.6M | $56.0M | $64.4M | $60.4M | $62.8M | $73.3M | $101.4M | $99.3M |
| Total Current Liabilities | $186.7M | $303.0M | $349.3M | $398.1M | $556.8M | $536.8M | $493.4M | $523.0M | $624.4M | $615.5M |
| Long-term Debt | $1.41B | $2.13B | $2.25B | $2.52B | $2.79B | $2.88B | $2.56B | $2.70B | $3.27B | $2.71B |
| Total Liabilities | $2.30B | $4.62B | $4.68B | $3.32B | $3.79B | $3.82B | $3.40B | $3.51B | $4.25B | $4.72B |
| Retained Earnings | -$311.4M | -$41.3M | -$247.0M | -$315.7M | -$431.8M | -$502.7M | -$557.3M | -$569.2M | -$737.3M | -$815.2M |
| Total Equity | $9.7M | $654.7M | $404.6M | $691.8M | $550.1M | $1.09B | $2.00B | $1.99B | $1.79B | $1.71B |
| Total Debt | $1.50B | $2.19B | $2.48B | $2.90B | $3.20B | $3.29B | $2.93B | $3.06B | $3.70B | $4.02B |
| Net Debt | $1.43B | $2.01B | $2.29B | $2.81B | $2.88B | $2.90B | $2.65B | $2.87B | $3.43B | $3.78B |
| Working Capital | $175.2M | $260.2M | $239.0M | $127.4M | $244.7M | $409.3M | $427.6M | $372.0M | $495.0M | $535.2M |
Financial Health
| Debt / Equity | 2.40 |
| Current Ratio | 1.95 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 0.75 |
Profitability
| Return on Equity | -5.21% |
| Return on Invested Capital | 4.39% |
| Return on Assets | -1.10% |
| Gross Margin | 21.37% |
| Operating Margin | 11.89% |
| Net Margin | -2.63% |
Related companies: HCA · THC · UHS · 0J1R.L · 0RPS.L · EHC · DVA · FMS
Explore sector: Healthcare · Medical - Care Facilities
More sections of SGRY: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks